Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells - Wikidata - awgldk - TriplyDB

Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells

Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells

http://www.wikidata.org/entity/Q24793862

about

The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo Mild hyperthermia enhances transport of liposomal gemcitabine and improves in vivo therapeutic response.Bladder uptake of liposomes after intravesical administration occurs by endocytosis Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer.RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines.Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity Nucleoside analogue delivery systems in cancer therapy.Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.Lipophilic prodrugs and formulations of conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancer.Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives.Targeting histone deacetylase in thyroid cancer.Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy.Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro.BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs.Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer.Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates.Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.Quantitative structure-property relationship modeling of remote liposome loading of drugs.Development of egg PC/cholesterol/α-tocopherol liposomes with ionic gradients to deliver ropivacaine.Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer.Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma

P2860

Q26827175-A2C3CEE4-4BA6-47FB-A768-595C61F6C555 Q27342656-DB92B442-5C00-4AE9-B489-72D8AEAAFE54 Q28545037-C567C88C-D579-491F-AB15-F1CB1D9DCEAF Q31098128-7493B3E6-DC45-4B2D-AE93-1B026D469F88 Q33894617-5B5F8675-4B89-4DAE-AC22-65AD7DBCE6C6 Q34165809-E6004188-AB44-407D-8C43-2A6BEFCF257C Q35659449-025DEF47-386C-4E20-96EB-0EA56160B952 Q35747497-CC9B6CA2-58B8-40A1-A3B1-402255460E17 Q36164785-F7AA8935-E0ED-4339-B6B8-AF2797BB5185 Q36945847-4D51D26C-12CD-4224-B663-FB80025BDD5B Q37426354-314A7C94-BE5A-489F-9098-8B2F6F59DB82 Q37955222-DDDEC314-0628-4E14-B126-478190193341 Q37963493-75954287-EBA2-498E-A270-0A16A98B3BDD Q38058785-9B8CEADF-7414-45AA-AE73-7E20F1279615 Q38066990-798713F5-276F-4A18-A1D0-5AB38D1A0037 Q38675367-415240B4-B749-4565-87F6-F8FC8E4E9ED1 Q38856634-8157BBDF-0DA1-41CF-8BB8-1CBFBE475A15 Q39139396-1BE28EA8-DDE1-4157-9368-38AA21F72D89 Q39140858-14248BEB-4C43-4862-9068-B8FA56FCEC03 Q39254075-59A06CFD-244B-4C3D-AFB1-F9BE537F7CF2 Q40036483-56FFA911-F051-45B7-8C60-F70A7833CFAC Q41382206-82BA3CC2-FD66-4AA1-9C9F-6AA86438C4A1 Q42322486-2DBAA069-53BA-4219-9ED6-60B9205CB7AF Q47730370-D1D5234E-6687-465B-B435-EC42A72CEB5F Q48637043-65F49131-1375-4600-B661-14A2C7AC58CD Q58700964-FF2C8ECD-CB06-4FA1-B992-623CA4953AA5

P2860

Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells

http://www.wikidata.org/entity/Q24793862

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@ast

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@en

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@nl

type

label

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@ast

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@en

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@nl

prefLabel

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@ast

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@en

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@nl

P1433

Q24793862-55C6CD1C-5ABF-4E61-AA90-A65A94287994

P1476

Q24793862-1EE31DB2-CEC3-40EE-A61F-049F8561FFC2

P2093

Q24793862-20C78FA2-2127-409D-AAFF-563B585DD26F

Q24793862-7F834DE6-CEF8-49B6-AA3F-1D42898591FD

Q24793862-8314A6F9-C4E5-4404-93FE-018D374C2292

Q24793862-A93F7C84-C5B2-4337-8A7F-24ABA42F4B0F

Q24793862-AB57453A-6C8D-4627-9BF3-E5C1A85DBBE2

Q24793862-B03B7555-3707-4DF0-B4C9-8AB6955E7173

Q24793862-B96655D5-3EF3-498D-8B80-59B430C087FB

Q24793862-E04E6C76-41FC-4011-83FF-3B4C02728C41

Q24793862-EECCCFE4-2337-41E8-B690-59EFE59F9E68

P2860

Q24793862-02637F81-6373-42A0-AC21-7EFBB1B5B045

Q24793862-31FDCB46-C319-49D5-AC71-18D18AA6FA0F

Q24793862-33C999B4-9760-4B3E-B172-4494B78D188C

Q24793862-47BAFD20-DE02-4A9A-B8BF-C6A5B7FFE891

Q24793862-507420C9-C98B-4D31-A47E-BBF93F731305

Q24793862-5C953D18-5851-409B-93AB-643BB16D1FE2

Q24793862-7BD75167-A803-4350-B62D-709A4B7733AD

Q24793862-7CDE611C-E14B-4023-987E-8A0F87FFC887

Q24793862-8FD779B1-5D5B-4A21-B6D0-5D66A4B0D847

Q24793862-A09CE7E3-4003-433F-9B03-A50E65CD6511

P2888

Q24793862-C53648A6-159C-4AEC-88A3-F7FFCF9CB852

P304

Q24793862-E381135F-32F0-4931-B6DE-C6D8143E5772

P31

Q24793862-495F7266-8877-45E5-AFAA-6081C37073FD

P356

Q24793862-3422950D-B3F3-4E8E-8676-53F9737F6E1E

P407

Q24793862-CE9ABD1A-E36B-4DDA-A52B-3D4C38CC62D9

P433

Q24793862-77023893-D02F-4EE7-90C8-5D4840B550F1

P478

Q24793862-AD20E752-096F-4696-BE92-ACF411AD4C61

P577

Q24793862-67039E8E-5921-4182-BD27-753432CF4668

P5875

Q24793862-EB11760C-1150-45A4-BC7B-F79C5540B2A0

P6179

Q24793862-077142D8-60C7-4694-BB0C-A0EDEFE45E7B

P698

Q24793862-23D8FF86-C484-450B-98F2-A0B9B3095C18

P921

Q24793862-DB36CB0B-E308-4F8E-960D-8ADD20B64091

P932

Q24793862-C72618DB-CDB9-456C-9FBF-7DF0A66FE685

P356

P1433

P1476

Cytotoxic effects of gemcitabi ...... lastic thyroid carcinoma cells

@en

P2093

Diego Russo

http://www.w3.org/2001/XMLSchema#string

Domenicoantonio Rotiroti

http://www.w3.org/2001/XMLSchema#string

Donatella Paolino

http://www.w3.org/2001/XMLSchema#string

Franco Arturi

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Calvagno

http://www.w3.org/2001/XMLSchema#string

Marilena Celano

http://www.w3.org/2001/XMLSchema#string

Massimo Fresta

http://www.w3.org/2001/XMLSchema#string

Sebastiano Filetti

http://www.w3.org/2001/XMLSchema#string

Stefania Bulotta

http://www.w3.org/2001/XMLSchema#string

P2860

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies

Chemotherapy for advanced pancreatic cancer.

Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation.

Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.

The sodium iodide symporter: its pathophysiological and therapeutic implications.

Anaplastic thyroid cancer.

Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.

Gemcitabine as a single-agent treatment for ovarian cancer.

Radiation sensitizers and targeted therapies.

P2888

P304

63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-4-63

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8351761

http://www.w3.org/2001/XMLSchema#string

P6179

1039966710

http://www.w3.org/2001/XMLSchema#string

P698

15363094

http://www.w3.org/2001/XMLSchema#string

P921

P932

517941

http://www.w3.org/2001/XMLSchema#string